Selected research
Industry Research
Drugs of Abuse Testing Systems Industry Research Report 2026
Market perspective
The global Drugs of Abuse Testing Systems market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Drugs of Abuse Testing Systems is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Drugs of Abuse Testing Systems is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Drugs of Abuse Testing Systems include Abbott, Thermo Fisher Scientific, Roche, Wondfo Biotech, Siemens Healthineers, Randox Laboratories, Orient Gene Biotech, OraSure and Intec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Drugs of Abuse Testing Systems market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drugs of Abuse Testing Systems Market by Company
Abbott
Thermo Fisher Scientific
Roche
Wondfo Biotech
Siemens Healthineers
Randox Laboratories
Orient Gene Biotech
OraSure
Intec
Hangzhou Biotest
Drager
Assure Tech (Hangzhou) Co
Aotai Bio
Drugs of Abuse Testing Systems Segment by Type
Urine Screening System
Saliva Test System
Others
Drugs of Abuse Testing Systems Segment by Application
Hospital
Laboratory
Others
Drugs of Abuse Testing Systems Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of Abuse Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs of Abuse Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of Abuse Testing Systems.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Drugs of Abuse Testing Systems manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Drugs of Abuse Testing Systems by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Drugs of Abuse Testing Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Urine Screening System
- Saliva Test System
- Others
Applications
- Hospital
- Laboratory
- Others
Companies covered
- Abbott
- Thermo Fisher Scientific
- Roche
- Wondfo Biotech
- Siemens Healthineers
- Randox Laboratories
- Orient Gene Biotech
- OraSure
- Intec
- Hangzhou Biotest
- Drager
- Assure Tech (Hangzhou) Co
- Aotai Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Drugs of Abuse Testing Systems Market Size (2021-2032)
- 2.2.2 Global Drugs of Abuse Testing Systems Sales (2021-2032)
- 2.2.3 Global Drugs of Abuse Testing Systems Market Average Price (2021-2032)
- 2.3 Drugs of Abuse Testing Systems by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Urine Screening System
- 2.3.3 Saliva Test System
- 2.3.4 Others
- 2.4 Drugs of Abuse Testing Systems by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Laboratory
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Drugs of Abuse Testing Systems Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Drugs of Abuse Testing Systems Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Drugs of Abuse Testing Systems Revenue of Manufacturers (2021-2026)
- 3.4 Global Drugs of Abuse Testing Systems Average Price by Manufacturers (2021-2026)
- 3.5 Global Drugs of Abuse Testing Systems Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Drugs of Abuse Testing Systems, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Drugs of Abuse Testing Systems, Product Type & Application
- 3.8 Global Manufacturers of Drugs of Abuse Testing Systems, Established Date
- 3.9 Global Drugs of Abuse Testing Systems Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Drugs of Abuse Testing Systems Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Company Information
- 4.2.2 Thermo Fisher Scientific Business Overview
- 4.2.3 Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 Roche
- 4.3.1 Roche Company Information
- 4.3.2 Roche Business Overview
- 4.3.3 Roche Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Roche Drugs of Abuse Testing Systems Product Portfolio
- 4.3.5 Roche Recent Developments
- 4.4 Wondfo Biotech
- 4.4.1 Wondfo Biotech Company Information
- 4.4.2 Wondfo Biotech Business Overview
- 4.4.3 Wondfo Biotech Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolio
- 4.4.5 Wondfo Biotech Recent Developments
- 4.5 Siemens Healthineers
- 4.5.1 Siemens Healthineers Company Information
- 4.5.2 Siemens Healthineers Business Overview
- 4.5.3 Siemens Healthineers Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolio
- 4.5.5 Siemens Healthineers Recent Developments
- 4.6 Randox Laboratories
- 4.6.1 Randox Laboratories Company Information
- 4.6.2 Randox Laboratories Business Overview
- 4.6.3 Randox Laboratories Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Randox Laboratories Drugs of Abuse Testing Systems Product Portfolio
- 4.6.5 Randox Laboratories Recent Developments
- 4.7 Orient Gene Biotech
- 4.7.1 Orient Gene Biotech Company Information
- 4.7.2 Orient Gene Biotech Business Overview
- 4.7.3 Orient Gene Biotech Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolio
- 4.7.5 Orient Gene Biotech Recent Developments
- 4.8 OraSure
- 4.8.1 OraSure Company Information
- 4.8.2 OraSure Business Overview
- 4.8.3 OraSure Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 OraSure Drugs of Abuse Testing Systems Product Portfolio
- 4.8.5 OraSure Recent Developments
- 4.9 Intec
- 4.9.1 Intec Company Information
- 4.9.2 Intec Business Overview
- 4.9.3 Intec Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Intec Drugs of Abuse Testing Systems Product Portfolio
- 4.9.5 Intec Recent Developments
- 4.10 Hangzhou Biotest
- 4.10.1 Hangzhou Biotest Company Information
- 4.10.2 Hangzhou Biotest Business Overview
- 4.10.3 Hangzhou Biotest Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolio
- 4.10.5 Hangzhou Biotest Recent Developments
- 4.11 Drager
- 4.11.1 Drager Company Information
- 4.11.2 Drager Business Overview
- 4.11.3 Drager Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Drager Drugs of Abuse Testing Systems Product Portfolio
- 4.11.5 Drager Recent Developments
- 4.12 Assure Tech (Hangzhou) Co
- 4.12.1 Assure Tech (Hangzhou) Co Company Information
- 4.12.2 Assure Tech (Hangzhou) Co Business Overview
- 4.12.3 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolio
- 4.12.5 Assure Tech (Hangzhou) Co Recent Developments
- 4.13 Aotai Bio
- 4.13.1 Aotai Bio Company Information
- 4.13.2 Aotai Bio Business Overview
- 4.13.3 Aotai Bio Drugs of Abuse Testing Systems Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Aotai Bio Drugs of Abuse Testing Systems Product Portfolio
- 4.13.5 Aotai Bio Recent Developments
5 Global Drugs of Abuse Testing Systems Market Scenario by Region
- 5.1 Global Drugs of Abuse Testing Systems Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Drugs of Abuse Testing Systems Sales by Region: 2021-2032
- 5.2.1 Global Drugs of Abuse Testing Systems Sales by Region: 2021-2026
- 5.2.2 Global Drugs of Abuse Testing Systems Sales by Region: 2027-2032
- 5.3 Global Drugs of Abuse Testing Systems Revenue by Region: 2021-2032
- 5.3.1 Global Drugs of Abuse Testing Systems Revenue by Region: 2021-2026
- 5.3.2 Global Drugs of Abuse Testing Systems Revenue by Region: 2027-2032
- 5.4 North America Drugs of Abuse Testing Systems Market Facts & Figures by Country
- 5.4.1 North America Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Drugs of Abuse Testing Systems Sales by Country (2021-2032)
- 5.4.3 North America Drugs of Abuse Testing Systems Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Drugs of Abuse Testing Systems Market Facts & Figures by Country
- 5.5.1 Europe Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Drugs of Abuse Testing Systems Sales by Country (2021-2032)
- 5.5.3 Europe Drugs of Abuse Testing Systems Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Drugs of Abuse Testing Systems Market Facts & Figures by Country
- 5.6.1 Asia Pacific Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Drugs of Abuse Testing Systems Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Drugs of Abuse Testing Systems Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Drugs of Abuse Testing Systems Market Facts & Figures by Country
- 5.7.1 South America Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Drugs of Abuse Testing Systems Sales by Country (2021-2032)
- 5.7.3 South America Drugs of Abuse Testing Systems Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Drugs of Abuse Testing Systems Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Drugs of Abuse Testing Systems Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Drugs of Abuse Testing Systems Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Drugs of Abuse Testing Systems Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Drugs of Abuse Testing Systems Sales by Type (2021-2032)
- 6.1.1 Global Drugs of Abuse Testing Systems Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Drugs of Abuse Testing Systems Sales Market Share by Type (2021-2032)
- 6.2 Global Drugs of Abuse Testing Systems Revenue by Type (2021-2032)
- 6.2.1 Global Drugs of Abuse Testing Systems Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Drugs of Abuse Testing Systems Revenue Market Share by Type (2021-2032)
- 6.3 Global Drugs of Abuse Testing Systems Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Drugs of Abuse Testing Systems Sales by Application (2021-2032)
- 7.1.1 Global Drugs of Abuse Testing Systems Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Drugs of Abuse Testing Systems Sales Market Share by Application (2021-2032)
- 7.2 Global Drugs of Abuse Testing Systems Revenue by Application (2021-2032)
- 7.2.1 Global Drugs of Abuse Testing Systems Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Drugs of Abuse Testing Systems Revenue Market Share by Application (2021-2032)
- 7.3 Global Drugs of Abuse Testing Systems Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Drugs of Abuse Testing Systems Value Chain Analysis
- 8.1.1 Drugs of Abuse Testing Systems Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Drugs of Abuse Testing Systems Production Mode & Process
- 8.2 Drugs of Abuse Testing Systems Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Drugs of Abuse Testing Systems Distributors
- 8.2.3 Drugs of Abuse Testing Systems Customers
9 Global Drugs of Abuse Testing Systems Analyzing Market Dynamics
- 9.1 Drugs of Abuse Testing Systems Industry Trends
- 9.2 Drugs of Abuse Testing Systems Industry Drivers
- 9.3 Drugs of Abuse Testing Systems Industry Opportunities and Challenges
- 9.4 Drugs of Abuse Testing Systems Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst